Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,442
Closed -$525K 553
2026
Q1
$525K Buy
+4,442
New +$549K 0.01% 333
2025
Q3
Sell
-2,923
Closed -$456K 412
2025
Q2
$456K Buy
2,923
+684
+31% +$108K 0.01% 253
2025
Q1
$369K Buy
+2,239
New +$372K 0.01% 273
2024
Q4
Sell
-6,562
Closed -$1.28M 450
2024
Q3
$1.28M Buy
6,562
+4,282
+188% +$789K 0.03% 209
2024
Q2
$395K Sell
2,280
-3,067
-57% -$510K 0.01% 288
2024
Q1
$905K Buy
+5,347
New +$1M 0.03% 227

Other funds holding ZTS

Allianz's ZTS Position: Q2 2026 in Review

Allianz sold out of Zoetis (ZTS) in Q2 2026, closing a stake of 4,442 shares — an estimated $525K sold.

Allianz first reported a position in ZTS in Q1 2024 and held it in 6 quarters. The position peaked at $1.28M in Q3 2024. 1,423 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Allianz reported no remaining Zoetis position as of Q2 2026 after selling out during the quarter.
  • Allianz sold 4,442 Zoetis shares in Q2 2026, an estimated $525K.
  • Allianz first reported a position in Zoetis in Q1 2024 and held it in 6 quarters.
  • Allianz's Zoetis position peaked at $1.28M in Q3 2024.
  • 1,423 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.